We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
Naltrexone and Hypoglycemia in Type 1 Diabetes
Updated: 1/22/2018
Study of the Effect of Naltrexone on Cerebral Blood Flow and Hypoglycemia in Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 1/22/2018
Naltrexone and Hypoglycemia in Type 1 Diabetes
Updated: 1/22/2018
Study of the Effect of Naltrexone on Cerebral Blood Flow and Hypoglycemia in Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 1/22/2018
Click here to add this to my saved trials
Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Updated: 1/22/2018
Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Status: Enrolling
Updated: 1/22/2018
Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Updated: 1/22/2018
Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Status: Enrolling
Updated: 1/22/2018
Click here to add this to my saved trials
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
Updated: 1/22/2018
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
Status: Enrolling
Updated: 1/22/2018
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
Updated: 1/22/2018
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
Status: Enrolling
Updated: 1/22/2018
Click here to add this to my saved trials
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Updated: 1/23/2018
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Status: Enrolling
Updated: 1/23/2018
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Updated: 1/23/2018
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Updated: 1/24/2018
A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 1/24/2018
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Updated: 1/24/2018
A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Generic vs. Name-Brand Levothyroxine
Updated: 1/24/2018
Generic vs. Name-Brand Levothyroxine: Assessment of Bioequivalence Using TSH as a Marker in Children With Permanent Hypothyroidism
Status: Enrolling
Updated: 1/24/2018
Generic vs. Name-Brand Levothyroxine
Updated: 1/24/2018
Generic vs. Name-Brand Levothyroxine: Assessment of Bioequivalence Using TSH as a Marker in Children With Permanent Hypothyroidism
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
SOM230 Ectopic ACTH-producing Tumors
Updated: 1/24/2018
A Proof of Concept and Open-label Study to Test the Efficacy and Safety of Pasireotide in Patients With Ectopic ACTH-producing Tumors
Status: Enrolling
Updated: 1/24/2018
SOM230 Ectopic ACTH-producing Tumors
Updated: 1/24/2018
A Proof of Concept and Open-label Study to Test the Efficacy and Safety of Pasireotide in Patients With Ectopic ACTH-producing Tumors
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Updated: 1/25/2018
Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Status: Enrolling
Updated: 1/25/2018
Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Updated: 1/25/2018
Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Updated: 1/25/2018
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Status: Enrolling
Updated: 1/25/2018
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Updated: 1/25/2018
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
Updated: 2/1/2018
The Brain, Neurological Features and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
Status: Enrolling
Updated: 2/1/2018
The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
Updated: 2/1/2018
The Brain, Neurological Features and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome
Updated: 2/2/2018
Modulating Physiologic Effects Of Phospholipid Metabolism In Obesity And Diabetes; AIM 4: Composition and Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome
Status: Enrolling
Updated: 2/2/2018
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome
Updated: 2/2/2018
Modulating Physiologic Effects Of Phospholipid Metabolism In Obesity And Diabetes; AIM 4: Composition and Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated: 2/2/2018
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated: 2/2/2018
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Muscle Lipid and Insulin Resistance in the Elderly
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Status: Enrolling
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Status: Enrolling
Updated: 2/3/2018
Click here to add this to my saved trials
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Click here to add this to my saved trials
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Click here to add this to my saved trials
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Updated: 2/7/2018
Environmental Triggers Of Cardiometabolic Disease
Status: Enrolling
Updated: 2/7/2018
Click here to add this to my saved trials
Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy
Updated: 2/8/2018
A Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Thyroidectomy and Parathyroidectomy
Status: Enrolling
Updated: 2/8/2018
Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy
Updated: 2/8/2018
A Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Thyroidectomy and Parathyroidectomy
Status: Enrolling
Updated: 2/8/2018
Click here to add this to my saved trials
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
Updated: 2/13/2018
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
Status: Enrolling
Updated: 2/13/2018
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
Updated: 2/13/2018
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Updated: 2/13/2018
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue
Status: Enrolling
Updated: 2/13/2018
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Updated: 2/13/2018
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
Smart Technology for Weight Loss and Metabolic Health
Updated: 2/13/2018
Smart Technology for Weight Loss and Metabolic Health- A Randomized Controlled Trial
Status: Enrolling
Updated: 2/13/2018
Smart Technology for Weight Loss and Metabolic Health
Updated: 2/13/2018
Smart Technology for Weight Loss and Metabolic Health- A Randomized Controlled Trial
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Updated: 2/15/2018
A Phase II Safety and Efficacy Study of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Children With Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated: 2/15/2018
Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Updated: 2/15/2018
A Phase II Safety and Efficacy Study of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Children With Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Muscle Insulin Resistance in Aging (Mirage)
Updated: 2/15/2018
Muscle Insulin Resistance In Aging
Status: Enrolling
Updated: 2/15/2018
Muscle Insulin Resistance in Aging (Mirage)
Updated: 2/15/2018
Muscle Insulin Resistance In Aging
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Cardiovascular Disease Risk Factors in Chinese American Immigrants
Updated: 2/15/2018
Chinese American Cardiovascular Health Assessment CHA-CHA
Status: Enrolling
Updated: 2/15/2018
Cardiovascular Disease Risk Factors in Chinese American Immigrants
Updated: 2/15/2018
Chinese American Cardiovascular Health Assessment CHA-CHA
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Updated: 2/15/2018
Localization of Focal Forms of Hyperinsulinism of Infancy With 18F-labeled L-fluoro-DOPA PET Scan
Status: Enrolling
Updated: 2/15/2018
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Updated: 2/15/2018
Localization of Focal Forms of Hyperinsulinism of Infancy With 18F-labeled L-fluoro-DOPA PET Scan
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Click here to add this to my saved trials
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Click here to add this to my saved trials
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Click here to add this to my saved trials
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Updated: 2/19/2018
Decision Support for Parents Receiving Information About Child's Rare Disease
Status: Enrolling
Updated: 2/19/2018
Click here to add this to my saved trials
Phlebotomy Study of Testosterone Undecanoate
Updated: 2/23/2018
Evaluation of Blood Collection Methodology Following Administration of a Single-Dose of an Oral Testosterone Undecanoate Formulation In Hypogonadal Men
Status: Enrolling
Updated: 2/23/2018
Phlebotomy Study of Testosterone Undecanoate
Updated: 2/23/2018
Evaluation of Blood Collection Methodology Following Administration of a Single-Dose of an Oral Testosterone Undecanoate Formulation In Hypogonadal Men
Status: Enrolling
Updated: 2/23/2018
Click here to add this to my saved trials
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Click here to add this to my saved trials
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Click here to add this to my saved trials
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Updated: 2/23/2018
An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study
Status: Enrolling
Updated: 2/23/2018
Click here to add this to my saved trials
Diabetes Prevention Program
Status: Enrolling
Updated: 2/28/2018
Updated: 2/28/2018
Diabetes Prevention Program
Status: Enrolling
Updated: 2/28/2018
Updated: 2/28/2018
Click here to add this to my saved trials
Insulin Resistance and Insulin Secretion
Updated: 2/28/2018
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Insulin Resistance and Insulin Secretion
Updated: 2/28/2018
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Insulin Resistance and Insulin Secretion
Updated: 2/28/2018
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Insulin Resistance and Insulin Secretion
Updated: 2/28/2018
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
Updated: 3/5/2018
An Open-Label Study of Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
Status: Enrolling
Updated: 3/5/2018
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
Updated: 3/5/2018
An Open-Label Study of Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
Updated: 3/5/2018
Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
Status: Enrolling
Updated: 3/5/2018
Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
Updated: 3/5/2018
Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Status: Enrolling
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Status: Enrolling
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Updated: 3/5/2018
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Updated: 3/7/2018
Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Hypoglycemia and Autonomic Nervous System Function
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Status: Enrolling
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
Hypoglycemia and Autonomic Nervous System Function
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Status: Enrolling
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Updated: 3/7/2018
Hypoglycemia and Autonomic Nervous System Function
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials
A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
Updated: 3/7/2018
An Open-Label, Long-Term Safety Study of Long-acting Human Growth Hormone Somavaratan (VRS-317) in Japanese Children With Growth Hormone Deficiency
Status: Enrolling
Updated: 3/7/2018
A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
Updated: 3/7/2018
An Open-Label, Long-Term Safety Study of Long-acting Human Growth Hormone Somavaratan (VRS-317) in Japanese Children With Growth Hormone Deficiency
Status: Enrolling
Updated: 3/7/2018
Click here to add this to my saved trials